[go: up one dir, main page]

ES2613952T3 - Nuevo procedimiento para preparar sales de tiotropio - Google Patents

Nuevo procedimiento para preparar sales de tiotropio Download PDF

Info

Publication number
ES2613952T3
ES2613952T3 ES06777919.9T ES06777919T ES2613952T3 ES 2613952 T3 ES2613952 T3 ES 2613952T3 ES 06777919 T ES06777919 T ES 06777919T ES 2613952 T3 ES2613952 T3 ES 2613952T3
Authority
ES
Spain
Prior art keywords
formula
compound
group
tiotropium salts
kat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06777919.9T
Other languages
English (en)
Inventor
Joerg Brandenburg
Waldemar Pfrengle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Application granted granted Critical
Publication of ES2613952T3 publication Critical patent/ES2613952T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Procedimiento para preparar sales de tiotropio de la fórmula 1**Fórmula** en donde X‾ puede significar un anión con carga negativa sencilla, caracterizado por que se hace reaccionar un compuesto de la fórmula 2**Fórmula** en donde Y‾ puede significar un anión lipófilo con carga negativa sencilla, distinto de X‾ , seleccionado del grupo consistente en hexafluorofosfato, tetrafluoroborato y tetrafenilborato, de manera especialmente preferible hexafluorofosfato o tetrafenilborato, en un solo paso, con un compuesto de la fórmula 3**Fórmula** en donde R significa un radical seleccionado del grupo consistente en metoxi, etoxi, propoxi, isopropoxi, isopropeniloxi, butoxi, O-N-succinimida, O-N-ftalimida, feniloxi, nitrofeniloxi, fluorofeniloxi, pentafluorofeniloxi, viniloxi, 2-aliloxi, -S-metilo, -S-etilo y -S-fenilo, en un disolvente adecuado y con adición de una base adecuada y un catalizador seleccionado del grupo consistente en zeolitas, alcóxidos, lipasas y aminas terciarias, para proporcionar un compuesto de la fórmula 4**Fórmula** pudiendo tener el grupo Y‾ los significados antes indicados, y se transforma el compuesto de la fórmula 4, sin aislamiento, mediante reacción con una sal Kat+X‾ , en donde Kat+ representa un catión seleccionado del grupo consistente en Li+, Na+, K+, Mg2+, Ca2+ y cationes orgánicos con N cuaternario y X‾ puede tener los significados antes indicados, en el compuesto de la fórmula 1.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7

Claims (1)

  1. imagen1
    imagen2
    imagen3
ES06777919.9T 2005-07-27 2006-07-24 Nuevo procedimiento para preparar sales de tiotropio Active ES2613952T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005035112 2005-07-27
DE102005035112A DE102005035112A1 (de) 2005-07-27 2005-07-27 Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
PCT/EP2006/064559 WO2007012626A2 (de) 2005-07-27 2006-07-24 Neues verfahren zur herstellung von tiotropiumsalzen

Publications (1)

Publication Number Publication Date
ES2613952T3 true ES2613952T3 (es) 2017-05-29

Family

ID=37110331

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06777919.9T Active ES2613952T3 (es) 2005-07-27 2006-07-24 Nuevo procedimiento para preparar sales de tiotropio

Country Status (24)

Country Link
US (5) US20070027320A1 (es)
EP (2) EP1910354B1 (es)
JP (1) JP5210861B2 (es)
KR (1) KR101299929B1 (es)
CN (2) CN101309920A (es)
AR (1) AR057690A1 (es)
AU (1) AU2006274012B2 (es)
BR (1) BRPI0614062B8 (es)
CA (1) CA2616222C (es)
DE (1) DE102005035112A1 (es)
DK (1) DK1910354T3 (es)
EA (1) EA014271B1 (es)
EC (1) ECSP088138A (es)
ES (1) ES2613952T3 (es)
HU (1) HUE032259T2 (es)
IL (1) IL188989A (es)
MX (1) MX2008001093A (es)
NO (2) NO340877B1 (es)
NZ (1) NZ566039A (es)
PL (1) PL1910354T3 (es)
TW (3) TWI486345B (es)
UA (1) UA94914C2 (es)
WO (1) WO2007012626A2 (es)
ZA (1) ZA200711113B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008089852A1 (de) * 2007-01-26 2008-07-31 Boehringer Ingelheim Pharma Gmbh & Co.Kg Neues verfahren zur herstellung von tiotropiumsalzen
EP1953156A1 (de) * 2007-01-29 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopiniumsalzen
EP1950196A1 (de) * 2007-01-29 2008-07-30 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Ammoniumhexafluorophosphaten
EP1997819A1 (de) * 2007-05-25 2008-12-03 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopinestern
EP2036898A2 (de) * 2007-09-13 2009-03-18 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von 1,3-Dioxolan-2Onen sowie von Carbonsäureestern durch Transacylierung unter Basischen Reaktionsbedingungen
JP6087492B2 (ja) * 2008-01-10 2017-03-01 ジェネリクス・[ユーケー]・リミテッド スコピンエステルを調製するための新規プロセス
EP2462140A2 (en) 2009-08-07 2012-06-13 Generics [UK] Limited Anhydrate of triotropium bromide
WO2011015884A1 (en) * 2009-08-07 2011-02-10 Generics [Uk] Limited Process to prepare scopine esters
CZ305012B6 (cs) * 2012-03-30 2015-03-25 Zentiva, K.S. Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu
WO2021133280A1 (en) * 2019-12-27 2021-07-01 Deva Holding An improved process for preparation of scopine hydrobromide

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US7441045B2 (en) * 1999-12-13 2008-10-21 F5 Networks, Inc. Method and system for balancing load distribution on a wide area network
US6934686B1 (en) 2000-06-30 2005-08-23 I2 Technologies Us, Inc. Warranty transaction system and method
US7574499B1 (en) * 2000-07-19 2009-08-11 Akamai Technologies, Inc. Global traffic management system using IP anycast routing and dynamic load-balancing
US6706726B2 (en) * 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) * 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
US7237017B1 (en) * 2001-03-13 2007-06-26 Panamsat Corporation Micronode in a satellite based content delivery system
US20020143798A1 (en) * 2001-04-02 2002-10-03 Akamai Technologies, Inc. Highly available distributed storage system for internet content with storage site redirection
JP2004530705A (ja) * 2001-05-25 2004-10-07 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 閉塞性気道疾患及びその他の炎症性疾患を治療するためのpde4インヒビター及びチオトロピウム又はその誘導体の組み合わせ
WO2003027906A2 (en) * 2001-09-28 2003-04-03 Savvis Communications Corporation System and method for policy dependent name to address resolutioin.
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US7305429B2 (en) * 2002-06-10 2007-12-04 Utstarcom, Inc. Method and apparatus for global server load balancing
EP1504756A1 (en) * 2003-08-06 2005-02-09 Kyowa Hakko Kogyo Co., Ltd Medicament compositions comprising a heterocyclic compound and an anticholinergic
ATE478071T1 (de) * 2003-11-03 2010-09-15 Boehringer Ingelheim Int Verfahren zur herstellung neuer tiotropiumsalze
HRP20100149T1 (hr) * 2003-11-03 2010-04-30 Boehringer Ingelheim International Gmbh Postupak priprave tiotropijevih soli
DE102004041253A1 (de) * 2004-08-26 2006-03-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen
CN101227905A (zh) * 2005-06-15 2008-07-23 贝林格尔·英格海姆国际有限公司 制备噻托铵盐的方法、噻托铵盐及其药物组合物

Also Published As

Publication number Publication date
US20070027320A1 (en) 2007-02-01
IL188989A (en) 2012-10-31
CN101309920A (zh) 2008-11-19
EP3153512A1 (de) 2017-04-12
UA94914C2 (ru) 2011-06-25
ZA200711113B (en) 2010-08-25
IL188989A0 (en) 2008-08-07
JP2009507769A (ja) 2009-02-26
US20150225395A1 (en) 2015-08-13
WO2007012626A3 (de) 2010-05-06
NO20170613A1 (no) 2008-02-13
WO2007012626A2 (de) 2007-02-01
KR20080032634A (ko) 2008-04-15
EP1910354A2 (de) 2008-04-16
DE102005035112A1 (de) 2007-02-15
TW201418252A (zh) 2014-05-16
EP1910354B1 (de) 2016-11-09
TWI443097B (zh) 2014-07-01
NO340877B1 (no) 2017-07-03
US20140323732A1 (en) 2014-10-30
CA2616222C (en) 2014-09-23
NZ566039A (en) 2011-07-29
MX2008001093A (es) 2008-03-11
US20130116435A1 (en) 2013-05-09
BRPI0614062B8 (pt) 2021-05-25
ECSP088138A (es) 2008-02-20
HUE032259T2 (en) 2017-09-28
EA014271B1 (ru) 2010-10-29
TW201418253A (zh) 2014-05-16
KR101299929B1 (ko) 2013-08-27
US20100210844A1 (en) 2010-08-19
BRPI0614062A2 (pt) 2011-03-09
BRPI0614062B1 (pt) 2020-11-17
TWI486345B (zh) 2015-06-01
AR057690A1 (es) 2007-12-12
CN104356129A (zh) 2015-02-18
JP5210861B2 (ja) 2013-06-12
PL1910354T3 (pl) 2017-04-28
EA200800324A1 (ru) 2008-08-29
NO20076681L (no) 2008-02-13
AU2006274012B2 (en) 2011-11-03
CA2616222A1 (en) 2007-02-01
TWI486346B (zh) 2015-06-01
TW200738704A (en) 2007-10-16
AU2006274012A1 (en) 2007-02-01
DK1910354T3 (en) 2017-02-13

Similar Documents

Publication Publication Date Title
ES2613952T3 (es) Nuevo procedimiento para preparar sales de tiotropio
AR032599A1 (es) Procedimiento para preparar aductos de mannich con contenido de poliisobutenfenol
HRP20220017T1 (hr) Postupci pripreme novih inhibitora idh1
ECSP099338A (es) Derivados de quiniclidina de ácido (hetero) arilcicloheptano carboxíclico como antagonistas del receptor muscarínico
AR095530A1 (es) Moduladores de p2x7
ES2617517T3 (es) Éteres THPE
AR088937A1 (es) Proceso para estabilizar el contenido bacteriano de preparaciones minerales acuosas que comprenden carbonato de calcio natural molido y/o carbonato de calcio precipitado y/o dolomita y/o carbonato de calcio reaccionado en superficie
AR074304A1 (es) Moduladores heterociclicos de gamma- secretasa
PE20121087A1 (es) Compuestos antiproliferativos, conjugados de los mismos, procedimientos para estos, y usos de los mismos
AR053994A1 (es) Sulfonilpirrolidinas sustituidas procedimiento para su preparacion y su uso como medicamentos
DOP2010000178A (es) Peptidil nitrilos como inhibidores de dipeptidil peptidasa i
MY157676A (en) Diphenyl-pyrazolopyridine derivatives,preparation thereof, and use thereof as nuclear receptor not modulators
AR085806A1 (es) Inhibidores triciclicos de girasa
ECSP109990A (es) Mejoras en compuestos organicos o relacionadas con los mismos
AR093832A1 (es) COMPUESTOS CON ACTIVIDAD ANTAGONISTA DE LOS RECEPTORES MUSCARINICOS Y ACTIVIDAD AGONISTA DEL RECEPTOR b2 ADRENERGICO
ES2557004T3 (es) Mejoras en o relacionadas con compuestos orgánicos
BR112012032251A2 (pt) processo para a preparação de derivados da 2, 2-difluoroetilamina pela alquilação com 2,2 difluoroetil-1-haloetanos
ES2532451T3 (es) Composición herbicida
ES2526902T3 (es) Procesos de producción de inhibidores de la girasa y topoisomerasa IV
AR056987A1 (es) Derivados de acetileno
AR053587A1 (es) Derivados de pirazol
AR090350A1 (es) Compuestos quimicos
RU2013144281A (ru) Композиция флуоресцентного отбеливающего агента
AR072880A1 (es) Derivados nitrogenados de la pancratistatina
CO6680619A2 (es) Formulaciones